1. Market Research
  2. > Pathology
32 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Potential Pipeline Disruptors

  • $ 4200
  • May 2017
  • 120 pages

FOLLICULAR LYMPHOMA TENDS TO BE INDOLENT AND DIFFUSE LYMPHOMA TENDS TO BE AGGRESSIVE.

  • Lymphoma
  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • AstraZeneca PLC

Potential "Pipeline Disruptors" - New Products That Will Drive The Future Pharmaceutical Market

  • $ 4200
  • May 2017
  • 120 pages

(% market share) CHAPTER ##: PIPELINE DISRUPTORS: LYMPHOMA MARKET OPPORTUNITY Non-Hodgkin' s Lymphoma Table ##-##: Classification of Non-Hodgkin' s Lymphomas Hodgkin' s Lymphoma Figure ##-##: Global Incidence and Mortality of Lymphoma by Country, 2012* THE HEAVY HITT

  • Lymphoma
  • Monoclonal Antibody
  • Pathology
  • Targeted Therapy
  • Therapy

World Prescription Dermatological Drugs Market, 10th Edition

  • $ 4200
  • June 2017
  • 414 pages

ITS PRINCIPAL INDICATIONS ARE FOR CENTRAL NERVOUS SYSTEM MALIGNANCIES, LYMPHOMAS, MELANOMA, AND GASTROINTESTINAL TUMORS.

  • Antifungal
  • Dermatological Condition
  • Lymphoma
  • Therapy
  • World

The World Market for Cancer Therapeutics by Product

  • $ 4200
  • November 2015
  • 320 pages

Follicular lymphoma tends to be indolent and diffuse lymphoma tends to be aggressive.

  • Cancer
  • Lymphoma
  • Targeted Therapy
  • Therapy
  • Novartis AG

The Worldwide Market for Liquid Biopsy 

  • $ 4200
  • July 2017
  • 210 pages

This report covers the market for liquid biopsy, including cfDNA, CTC and other technologies. The market data in this report is segmented by those technologies type of cancer tested and by purpose - testing, ...

  • Biotech Diagnostics
  • Cancer
  • Genetic Testing
  • Genomics
  • Lymphoma

Surgical Procedure Volumes: Global Analysis (United States, China, Japan, Brazil, United Kingdom, Germany, France, Italy, Mexico, Australia, Canada)

  • $ 4200
  • May 2016
  • 271 pages

Other cancers with high incidence include prostate, stomach, liver, cervical, esophageal, bladder and lymphoma.

  • Cardiology
  • Health Services
  • Hospital
  • Lymphoma
  • World

Healthcare-Associated Infection Testing (HAI)

  • $ 2500
  • September 2017
  • 113 pages

This report takes a look at both prevention procedures such as sterilization and surface area disinfection and testing such as molecular tests and immunoassays. Infection control in healthcare facilities ...

  • Hospital
  • Infection Control
  • Lymphoma
  • Cepheid
  • Roche Group

Bioinformatics for Next-Generation Sequencing

  • $ 1500
  • June 2017
  • 96 pages

IN THE INITIAL PHASE OF THE PROGRAM, PARTICIPATING ORGANIZATIONS WILL APPLY WATSON TO THE DNA DATA OF PATIENTS WHO ARE BATTLING ALL TYPES OF CANCER, INCLUDING LYMPHOMA, MELANOMA, PANCREATIC, OVARIAN, BRAIN, LUNG, BREAST AND COLORECTAL CANCER.

  • Biotech Diagnostics
  • Genomics
  • Lymphoma
  • Molecular Diagnostics
  • Illumina, Inc.

MicroRNA Tools and Services Market

  • $ 4200
  • May 2016
  • 197 pages

THE INHIBITION OF MIR-## IN LYMPHOMA CELLS WAS FOUND TO RESTORE NORMAL FUNCTION AND REDUCE THE PROLIFERATION OF CANCEROUS CELLS.

  • Biotech Diagnostics
  • Genomics
  • Lymphoma
  • Molecular Diagnostics
  • RNA

The World Market for Infectious Disease Diagnostic Tests

  • $ 4500
  • November 2015
  • 300 pages

Chronic infection with the virus has been associated with adult T-cell leukemia/ lymphoma and HTLV-associated myelopathy/ tropical spastic paraparesis.

  • Diagnostics
  • Immunodiagnostics
  • Infectious Disease
  • Lymphoma
  • Molecular Diagnostics

World Market for Prescription Dermatological Drugs, 9th Edition

  • $ 4200
  • August 2015
  • 446 pages

Its principal indications are for central nervous system malignancies, lymphomas, melanoma, and gastrointestinal tumors.

  • Autoimmune Disease
  • Dermatological Condition
  • Lymphoma
  • Pharmaceutical
  • Therapy

Hospital-Acquired Infection (HAI) Control Market (Disinfection, Sterilization, Treatment, Testing)

  • $ 4200
  • January 2016
  • 225 pages

Hospital Acquired Infections Control ##th HOSPITAL ACQUIRED INFECTION (HAI) MARKETS A KALORAMA INFORMATION MARKET INTELLIGENCE REPORT Hospital Acquired Infection Control Markets has been prepared by Kalorama Information.

  • Anti-Infective
  • Antibiotic Resistance
  • Hospital
  • Infection Control
  • Lymphoma

Blood Screening and Typing Markets

  • $ 2500
  • January 2016
  • 117 pages

Blood Screening and Typing Markets ##th Blood Screening and Typing Markets A KALORAMA INFORMATION MARKET INTELLIGENCE REPORT Blood Screening and Typing Markets has been prepared by Kalorama Information.

  • Blood Supply
  • Infectious Disease
  • Lymphoma
  • Molecular Diagnostics
  • United States

IVD in India

  • $ 4200
  • January 2016
  • 240 pages

EBV has also been implicated as a contributing cause of several more serious diseases including cancer, including Hodgkin' s disease, post-transplant and other lymphomas, nasopharyngeal carcinoma (the most common head and neck cancer in large regions of Asia), breast cancer and Burkitt&

  • In Vitro Diagnostics
  • Infectious Disease
  • Laboratory
  • Lymphoma
  • India

The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Others)

  • $ 2995
  • January 2016
  • 110 pages

A MAJOR APPLICATION IS IMMUNOPHENOTYPING LEUKEMIA AND LYMPHOMA CELLS, A PROCESS THAT IS CRITICAL TO THE DIAGNOSIS OF THE TYPE OF LEUKEMIA OR LYMPHOMA THAT A PATIENT HAS.

  • Diagnostics
  • Lymphoma
  • Molecular Diagnostics
  • Sexually Transmitted Disease
  • United States

IVD Market in Vietnam

  • $ 2995
  • August 2015
  • 43 pages

The IVD Market in Vietnam ##th THE IVD MARKET IN VIETNAM IVD in Vietnam has been prepared by Kalorama Information.

  • In Vitro Diagnostics
  • Lymphoma
  • Vietnam
  • Roche Group
  • Sysmex Corporation

The World Market for Point of Care (POC) Diagnostics

  • $ 4200
  • June 2015
  • 354 pages

Although the vast majority of infected individuals are asymptomatic carriers, HTLV infection is known to cause Adult T-cell leukemia/ lymphoma (ATLL), and HTLV-I-associated myelopathy (HAM) in some patients.

  • Diagnostics
  • Laboratory
  • Lymphoma
  • Point Of Care Testing
  • World

IVD in China

  • $ 3500
  • June 2015
  • 264 pages

EBV has also been implicated as a contributing cause of several more serious diseases including cancer, including Hodgkin' s disease, post-transplant and other lymphomas, nasopharyngeal carcinoma (the most common head and neck cancer in large regions of Asia), breast cancer and Burkitt&

  • Healthcare
  • In Vitro Diagnostics
  • Infectious Disease
  • Lymphoma
  • China

Clinical Diagnostics PCR Markets by Type and Region

  • $ 3500
  • June 2017
  • 260 pages

San Diego, California / www. invivoscribe. com Invivoscribe Technologies, Inc. was founded in 1995, and has focused on molecular diagnostic reagents for leukemia and lymphoma testing.

  • Biotech Diagnostics
  • Infectious Disease
  • Lymphoma
  • Molecular Diagnostics
  • Biocartis S.A.

The Worldwide Market for Lab-Developed Test Services and the Market for Instruments and Reagents Sold to Labs

  • $ 4500
  • September 2017
  • 375 pages

FOCUS::DLBCL& FL™ - DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA FOCUS::NGS® TESTS - NEXT GENERATION SEQUENCING BASED DIAGNOSTIC TESTS TO PROVIDE A COMPREHENSIVE VIEW OF A TUMOR' S GENOMIC PROFILE. o o o o o o o o O MYELOID PANELS: o o o o o o FOCUS::HERSITE™ - HERE

  • Genomics
  • Health Services
  • Laboratory
  • Lymphoma
  • Molecular Diagnostics
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on